Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by José Sanz
All-Oral DAA Therapy Against HCV in HIV/HCV-coinfected Subjects in Real-World Practice: Madrid-CoRe Findings
Hepatology
Medicine
Hepatology
Related publications
Liver Fibrosis Progression Despite HCV Cure With Antiviral Therapy in HIV–HCV-coinfected Patients
Antiviral Therapy
Infectious Diseases
Pharmacology
Efficacy and Safety of Hepatitis C Direct-Acting Protease Inhibitors (DAA-PI ) in Real Life in HIV-HCV Coinfected Patients
BMC Infectious Diseases
Infectious Diseases
Hepatic Steatosis in HIV-HCV Coinfected Patients Receiving Antiretroviral Therapy Is Associated With HCV-related Factors but Not Antiretrovirals
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers
HIV Clinical Trials
Real World Effectiveness of Ledipasvir/Sofosbuvir (LDV/SOF) for 8 Weeks in Patients Coinfected With HCV and HIV-1
Journal of Hepatology
Hepatology
Recent Advances in Management of the HIV/HCV Coinfected Patient
Future Virology
Virology
Efficacy and Tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected Patients With Psychiatric Disorders
BMC Infectious Diseases
Infectious Diseases
Benefit of Direct-Acting Antiviral Therapy for Hepatitis C Virus (HCV) in Monoinfected and HIV-HCV Coinfected Patients With Mixed Cryoglobulinemia
Clinical Microbiology and Infection
Medicine
Infectious Diseases
Microbiology
Survival of HIV/HCV Co-Infected Patients Before Introduction of HCV Direct Acting Antivirals (DAA)
Scientific Reports
Multidisciplinary